Genovate Biotechnology Co Ltd (4130) — Long-term Investment Intensity
Genovate Biotechnology Co Ltd (4130) has a Long-term Investment Intensity of 28.8% as of September 2019. Long-term investments of NT$469.06 Million represent 28.8% of total assets of NT$1.63 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Genovate Biotechnology Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Genovate Biotechnology Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Genovate Biotechnology Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 28.8%, reflecting long-term investments of NT$469.06 Million against total assets of NT$1.63 Billion TWD. Explore Genovate Biotechnology Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Genovate Biotechnology Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Genovate Biotechnology Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Genovate Biotechnology Co Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 33.6% | NT$583.08 Million | NT$1.74 Billion | ▲ +6.3 pp |
| 2017 | 27.2% | NT$556.21 Million | NT$2.04 Billion | ▼ -20.5 pp |
| 2016 | 47.8% | NT$1.26 Billion | NT$2.65 Billion | ▲ +4.2 pp |
| 2015 | 43.5% | NT$1.10 Billion | NT$2.52 Billion | — |